| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Chief R&D Officer | See Remarks +1 more
1 company
Valamehr Bahram is a President And CEO at FATE THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | FATE Fate Therapeutics Inc | President And CEO | Sell | 5,190 | $1.07 | $5,557.45 | -1.5% | +21.0% | - | |
| Aug 4, 2025 | FATE Fate Therapeutics Inc | President And CEO | Sell | 14,466 | $1.06 | $15,396.16 | -4.1% | +18.9% | - | |
| Jan 10, 2025 | FATE Fate Therapeutics Inc | President And CEO | Sell | 8,705 | $1.54 | $13,405.70 | -2.4% | -36.2% | -28.3% | |
| Jan 9, 2024 | FATE Fate Therapeutics Inc | Chief R&D Officer | Sell | 11,271 | $4.38 | $49,366.98 | -6.7% | +52.2% | -62.1% | |
| Jan 10, 2023 | FATE Fate Therapeutics Inc | Chief R&D Officer | Sell | 10,917 | $5.24 | $57,205.08 | -6.1% | -0.2% | -16.8% | |
| Jul 7, 2022 | FATE Fate Therapeutics Inc | Chief R&D Officer | Sale+OE | 17,158 | $30.23 | $518,686.34 | -8.7% | -23.8% | -84.6% | |
| Jul 6, 2022 | FATE Fate Therapeutics Inc | Chief R&D Officer | Sale+OE | 7,842 | $30.07 | $235,808.94 | -4.2% | -16.8% | -83.7% | |
| Mar 14, 2022 | FATE Fate Therapeutics Inc | Chief R&D Officer | Sale+OE | 25,000 | $31.07 | $776,732.85 | -2.7% | -40.1% | -81.5% | |
| Jan 11, 2022 | FATE Fate Therapeutics Inc | Chief R&D Officer | Sell | 4,570 | $48.50 | $221,655.04 | -1.5% | -24.6% | -88.0% | |
| Jan 10, 2022 | FATE Fate Therapeutics Inc | Chief R&D Officer | Sell | 5,596 | $46.38 | $259,557.52 | -1.8% | -27.3% | -88.9% |